Ambarella, Inc. (AMBA) Analysts See $0.08 EPS; Genocea Biosciences (GNCA) Sellers Decreased By 16.42% Their Shorts

February 17, 2018 - By Vivian Currie

Analysts expect Ambarella, Inc. (NASDAQ:AMBA) to report $0.08 EPS on February, 27.They anticipate $0.46 EPS change or 85.19% from last quarter’s $0.54 EPS. AMBA’s profit would be $2.67 million giving it 150.84 P/E if the $0.08 EPS is correct. After having $0.34 EPS previously, Ambarella, Inc.’s analysts see -76.47% EPS growth. The stock decreased 1.57% or $0.77 during the last trading session, reaching $48.27. About 350,463 shares traded. Ambarella, Inc. (NASDAQ:AMBA) has risen 67.32% since February 17, 2017 and is uptrending. It has outperformed by 50.62% the S&P500.

Genocea Biosciences Incorporated (NASDAQ:GNCA) had a decrease of 16.42% in short interest. GNCA’s SI was 2.26M shares in February as released by FINRA. Its down 16.42% from 2.70 million shares previously. With 544,200 avg volume, 4 days are for Genocea Biosciences Incorporated (NASDAQ:GNCA)’s short sellers to cover GNCA’s short positions. The SI to Genocea Biosciences Incorporated’s float is 10.16%. The stock increased 2.02% or $0.02 during the last trading session, reaching $1. About 315,649 shares traded. Genocea Biosciences, Inc. (NASDAQ:GNCA) has risen 67.22% since February 17, 2017 and is uptrending. It has outperformed by 50.52% the S&P500.

Since September 18, 2017, it had 0 buys, and 11 selling transactions for $3.18 million activity. $300,716 worth of Ambarella, Inc. (NASDAQ:AMBA) shares were sold by Kohn Leslie. Shares for $678,132 were sold by Chen Yun-Lung on Monday, December 11. Laplante George sold $242,413 worth of Ambarella, Inc. (NASDAQ:AMBA) on Monday, December 18. 11,629 Ambarella, Inc. (NASDAQ:AMBA) shares with value of $540,749 were sold by Wang Feng-Ming. Day Christopher sold 1,529 shares worth $71,099. On Monday, December 11 PAISLEY CHRISTOPHER B sold $118,463 worth of Ambarella, Inc. (NASDAQ:AMBA) or 2,000 shares.

Investors sentiment increased to 1.21 in 2017 Q3. Its up 0.29, from 0.92 in 2017Q2. It is positive, as 27 investors sold Ambarella, Inc. shares while 45 reduced holdings. 34 funds opened positions while 53 raised stakes. 19.99 million shares or 9.13% more from 18.32 million shares in 2017Q2 were reported. State Of Wisconsin Inv Board has invested 0.02% in Ambarella, Inc. (NASDAQ:AMBA). Schwab Charles Management holds 53,300 shares. Deutsche Fincl Bank Ag holds 505,603 shares. Advisory Net Limited Com accumulated 1,745 shares. Odey Asset Limited has 0.08% invested in Ambarella, Inc. (NASDAQ:AMBA). Illinois-based Guggenheim Cap Ltd has invested 0% in Ambarella, Inc. (NASDAQ:AMBA). Pinnacle Associate reported 1.01 million shares stake. Moreover, Barclays Public Lc has 0% invested in Ambarella, Inc. (NASDAQ:AMBA) for 42,483 shares. Nomura Asset Mngmt invested in 10,500 shares. Clearbridge Investments Ltd Liability Corp holds 309,163 shares. Driehaus Cap Management Llc stated it has 4,100 shares. Reliant Invest Mngmt Limited Liability reported 1.29% of its portfolio in Ambarella, Inc. (NASDAQ:AMBA). 680 were reported by Hall Laurie J Trustee. Commonwealth Equity Serv Incorporated holds 28,520 shares or 0.01% of its portfolio. Creative Planning has 0% invested in Ambarella, Inc. (NASDAQ:AMBA) for 7,334 shares.

Among 21 analysts covering Ambarella Corporation (NASDAQ:AMBA), 14 have Buy rating, 1 Sell and 6 Hold. Therefore 67% are positive. Ambarella Corporation had 69 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of Ambarella, Inc. (NASDAQ:AMBA) has “Neutral” rating given on Monday, March 7 by Chardan Capital Markets. Canaccord Genuity maintained it with “Buy” rating and $87 target in Wednesday, October 12 report. The company was maintained on Thursday, August 24 by Stifel Nicolaus. Stifel Nicolaus maintained Ambarella, Inc. (NASDAQ:AMBA) rating on Friday, December 2. Stifel Nicolaus has “Buy” rating and $84 target. Oppenheimer maintained Ambarella, Inc. (NASDAQ:AMBA) on Wednesday, June 7 with “Hold” rating. As per Friday, September 4, the company rating was downgraded by Zacks. The firm has “Perform” rating by Oppenheimer given on Friday, April 8. The rating was maintained by FBN Securities on Friday, December 4 with “Outperform”. The stock of Ambarella, Inc. (NASDAQ:AMBA) earned “Overweight” rating by Morgan Stanley on Tuesday, March 29. The stock of Ambarella, Inc. (NASDAQ:AMBA) has “Buy” rating given on Wednesday, June 7 by Roth Capital.

Ambarella, Inc. develops semiconductor processing solutions for video that enable high-definition video capture, sharing, and display worldwide. The company has market cap of $1.61 billion. The company's system-on-a-chip creates integrated HD video processing, image processing, audio processing, and system functions onto a single chip for delivering video and image quality, differentiated functionality, and low power consumption. It has a 46.46 P/E ratio. The Company’s solutions enable the creation of video content for wearable sports cameras, automotive aftermarket cameras, and professional and consumer Internet Protocol (IP) security cameras, as well as cameras incorporated into unmanned aerial vehicles in the camera market; and manage IP video traffic, broadcast encoding and transcoding, and IP video delivery applications in the infrastructure market.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: